TMA-6 (2,4,6-Trimetoxianfetamina) inhibe a la potenciacion de largo plazo (LTP) 
evocada in vivo en corteza prefrontal de ratas Sprague Dawley

Burgos-Villaseca, J; Klink, A; Klagges-Troncoso, J; Castro-Castillo, V; Barra, R; Burgos, H; Hernández, A; Sáez- Briones, P

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Meeting Abstract

TMA-6 (2,4,6-Trimetoxianfetamina) inhibe a la potenciacion de largo plazo (LTP) evocada in vivo en corteza prefrontal de ratas Sprague Dawley

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

https://www.sofarchi.cl/wp-content/uploads/Revista-SOFARCHI-A%C3%B1o2016-N2-1.pdf
(Abstract)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Burgos-Villaseca, J., Klink, A., Klagges-Troncoso, J., Castro-Castillo, V., Barra, R., Burgos, H., et al. (2016). TMA-6 (2,4,6-Trimetoxianfetamina) inhibe a la potenciacion de largo plazo (LTP) evocada in vivo en corteza prefrontal de ratas Sprague Dawley. Revista de Farmacología de Chile, 9(2): 71, 95.

Cite as: https://hdl.handle.net/21.11116/0000-0009-FD2A-C

Abstract

TMA-6
(2,4,6-trimethoxyamphetamine) inhibits long -term potentiation
(LTP) evoked in vivo in the prefrontal cortex of Sprague Dawley
rats.